| KDMN Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the KDMN shares outstanding history going back to 7/27/2016:
Also see: KDMN Market Cap History KDMN YTD Return |
KDMN Shares Outstanding History — Kadmon Holdings Share Count Over Time
As of 11/1/2021 Kadmon Holdings has 178.52 million KDMN shares outstanding. Investors often track the KDMN shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows KDMN share count trends over time, with 25 historical shares outstanding datapoints presented, dating back to 7/27/2016.
| KDMN Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||
KDMN Historical Shares Outstanding: +29.97% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| KDMN Stock Price Chart |
| About Kadmon Holdings Inc |
| Kadmon Holdings is a biopharmaceutical company. Co.'s clinical pipeline includes treatments for immune and fibrotic diseases as well as immuno-oncology therapies. Co. is developing oral small molecule inhibitors of Rho-associated coiled-coil kinase (ROCK) to treat immune and fibrotic diseases. Co.'s main product candidate, Belumosudil (KD025), is an orally administered, selective small molecule inhibitor of ROCK 2. Belumosudil is for the treatment of patients with chronic graft-versus-host disease (cGVHD). In addition to cGVHD, Co. is developing belumosudil in for the treatment of systemic sclerosis, an autoimmune disease characterized by chronic inflammation, fibrosis and vascular damage. We show 25 historical shares outstanding datapoints in our coverage of KDMN's shares outstanding history. Understanding the changing numbers of KDMN shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like KDMN versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching KDMN by allowing them to research KDMN shares outstanding history as well as any other stock in our coverage universe. |
| KDMN Current Stock Quote |
Quotes delayed 20 minutes  Free KDMN Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| KDMN Share Performance |
| Shares Outstanding Peers |
| Kadmon Holdings (KDMN) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
KDNY Shares Outstanding History KEQU Shares Outstanding History KERX Shares Outstanding History KIDS Shares Outstanding History KIN Shares Outstanding History KLDO Shares Outstanding History KLRS Shares Outstanding History KMPH Shares Outstanding History KND Shares Outstanding History KNTE Shares Outstanding History More Healthcare companies » |
KDMN Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
